Literature DB >> 3486649

Antithrombin, prekallikrein, and fibronectin levels in surgical patients.

R F Wilson, E F Mammen, M C Robson, J P Heggers, G Soullier, P A DePoli.   

Abstract

Antithrombin (AT), prekallikrein (PK), and fibronectin (FN) levels were measured in the plasma of 290 patients. The mean (+/- SD) lowest AT level measured in 287 patients was 70% +/- 18% (normal, 75% to 120% of control). The mean lowest AT level in 81 septic patients (49% +/- 17%) was significantly lower than in the 206 patients without sepsis (78% +/- 22%). The mean AT level in 60 patients who died (42% +/- 22%) was significantly lower than in 227 patients who lived (78% +/- 19%). The mean lowest PK level measured in 71 patients was 42% +/- 17% (normal, 80% to 120%). The mean PK level in 32 septic patients (26% +/- 12%) was significantly lower than in 39 patients who were not septic (54% +/- 19%). The mean lowest FN level measured in 45 patients was 193 +/- 86 micrograms/mL (normal, 160 to 240 micrograms/mL). The mean FN level in 15 septic patients (128 +/- 72 micrograms/mL) was significantly lower than in the 30 nonseptic patients (266 +/- 84 micrograms/mL). Following AT, PK, and FN levels in critically ill surgical patients may allow earlier diagnosis and more effective treatment of sepsis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486649     DOI: 10.1001/archsurg.1986.01400060029002

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

Authors:  F Baudo; T M Caimi; F de Cataldo; A Ravizza; S Arlati; G Casella; D Carugo; G Palareti; C Legnani; L Ridolfi; R Rossi; A D'Angelo; L Crippa; D Giudici; G Gallioli; A Wolfler; G Calori
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 2.  The adult respiratory distress syndrome--20 years on.

Authors:  D J Shale
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

3.  Use of antithrombin III in critical patients.

Authors:  J M Díaz-Cremades; R Lorenzo; M Sánchez; M J Moreno; M J Alsar; J M Bosch; L Fajardo; D González; D Guerrero
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

4.  [Follow-up of infected patients in an intensive care unit using the "infection score," endotoxin and AT III determination].

Authors:  R Grundmann; M Hornung
Journal:  Langenbecks Arch Chir       Date:  1988

Review 5.  Coagulation disorders in septic shock.

Authors:  L G Thijs; J P de Boer; M C de Groot; C E Hack
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

6.  Influence of modest endotoxemia on postoperative antithrombin deficiency and circulating secretory immunoglobulin a levels.

Authors:  Tetsuji Fujita; Takashi Imai; Sadao Anazawa
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

7.  Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resection.

Authors:  Carlo Pulitanò; Luca Aldrighetti; Marcella Arru; Renato Finazzi; Laura Soldini; Marco Catena; Gianfranco Ferla
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

8.  Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.

Authors:  Damien du Cheyron; Bruno Bouchet; Cédric Bruel; Cédric Daubin; Michel Ramakers; Pierre Charbonneau
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.